PlainRecalls
FDA Drug Moderate Class II Ongoing

MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10

Reported: May 22, 2024 Initiated: April 25, 2024 #D-0499-2024

Product Description

MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10

Reason for Recall

Presence of Particulate Matter: Potential for black particulates in the drug product.

Details

Recalling Firm
Sagent Pharmaceuticals
Units Affected
14,360 vials
Distribution
Nationwide in the USA
Location
Schaumburg, IL

Frequently Asked Questions

What product was recalled?
MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10. Recalled by Sagent Pharmaceuticals. Units affected: 14,360 vials.
Why was this product recalled?
Presence of Particulate Matter: Potential for black particulates in the drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 22, 2024. Severity: Moderate. Recall number: D-0499-2024.